Hidenori Yoshii

Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ

Tony K.T. Lam, Hidenori Yoshii, C. Andrew Haber et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 194 citations

Life Sciences, Biochemistry, Endocrinology +17

Free fatty acids impair hepatic insulin extraction in vivo.

Stephanie R. Wiesenthal, Harmanjit Sandhu, Richard H. McCall et al. · Diabetes · 1999 · 171 citations

Pharmacy, Biochemistry, Endocrinology +17

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Tomoya Mita, Naoto Katakami, Hidenori Yoshii et al. · Diabetes Care · 2015 · 163 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa et al. · Diabetes Care · 2016 · 141 citations

Medicine, Endocrinology, Pharmacology +17

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa et al. · Cardiovascular Diabetology · 2020 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17